Investigational Drug Details
| Drug ID: | D244 |
| Drug Name: | Nivocasan |
| Synonyms: | GS-9450 |
| Type: | Chemical drug |
| DrugBank ID: | DB12720 |
| DrugBank Description: | Nivocasan has been used in trials studying the treatment of HCV Infection and Nonalcoholic Steatohepatitis. |
| PubChem ID: | 11633038 |
| CasNo: | 908253-63-4 |
| Repositioning for NAFLD: | No |
| SMILES: | C(=O)(N[C@@H]1[C@](CF)(O)OC(=O)C1)[C@]1(C(C)C)CC(=NO1)c1c2c(ccn1)cccc2 |
| Structure: |
|
| InChiKey: | VYFGDLGHHBUDTQ-ZLGUVYLKSA-N |
| Molecular Weight: | 415.421 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | -- |
| Therapeutic Category: | Protective drug |
| Clinical Trial Progress: | Phase 2 completed (NCT00740610) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|